In view of the micromolar (~50–70 μM) concentration of L-asparagine in circulation [24,25], the millimolar affinity of Class 2 L-asparaginases is too low for use in ALL therapy. This evidence concerns the gene ASPG and acute lymphoblastic leukemia.